Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > IMRX Immuneering > Detailed Quotes

IMRX Immuneering

Watchlist
5.930
-0.530-8.20%
Close 12/02 16:00 ET
High
6.410
Open
6.270
Turnover
256.69K
Low
5.750
Pre Close
6.460
Volume
42.81K
Market Cap
156.58M
P/E(TTM)
Loss
52wk High
23.970
Shares
26.40M
P/E(Static)
Loss
52wk Low
3.740
Float Cap
82.15M
Bid/Ask %
-33.33%
Historical High
33.990
Shs Float
13.85M
Volume Ratio
1.32
Historical Low
3.740
Dividend TTM
--
Div Yield TTM
--
P/B
1.28
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.31%
Amplitude
10.22%
Avg Price
5.995
Lot Size
1
Float Cap
82.15M
Bid/Ask %
-33.33%
Historical High
33.990
Shs Float
13.85M
Volume Ratio
1.32
Historical Low
3.740
Dividend TTM
--
P/B
1.28
Dividend LFY
--
Turnover Ratio
0.31%
Amplitude
10.22%
Avg Price
5.995
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Immuneering Corp. engages in the development of new medicines which are unlikely to be found by traditional drug discovery methods. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis. The company was founded by Robert J. Carpenter and Benjamin J. Zeskind in 2008 and is headquartered in Cambridge, MA.
CEO: Dr. Benjamin J. Zeskind, PhD
Market: NASDAQ
Listing Date: 07/30/2021
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist